Andrew Donohue
Corporate Officer/Principal at PolyActiva Pty Ltd.
Network origin in Andrew Donohue first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
PolyActiva Pty Ltd.
 PolyActiva Pty Ltd. BiotechnologyHealth Technology PolyActiva Pty Ltd. develops drug-polymer conjugate technology. Its platform technology is used to make plastic components for medical devices from drugs and manufacture process is novel and provides greater flexibility over the composition of the final material and better product outcomes compared with competitor technologies. The firm has built drug-polymer conjugates from a number of drug candidates with different chemical structures and linkage points, demonstrating the plasticity of the technology and developed a number of functional co-monomers and polymer segments, which modularises the production of the final conjugate. The company was founded in February 2010 and is headquartered in Melbourne, Australia.
6
| Holding Company | Biotechnology | 6 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Andrew Donohue via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Bausch & Lomb, Inc.
 Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | Medical Specialties | Corporate Officer/Principal | |
| SAMSARA VISION, INC. | Medical Specialties | Director/Board Member | |
| EBR SYSTEMS, INC. | Medical Specialties | Director/Board Member | |
Layerbio, Inc.
 Layerbio, Inc. Miscellaneous Commercial ServicesCommercial Services Layerbio, Inc. develops bio erodible sustained-release technology for use in standard intraocular lens in cataract surgery. The private company is based in Lexington, MA. The company was founded in 2013 by Kenneth J. Mandell, Paula Hammond. Kenneth J. Mandell has been the CEO since 2013. | Miscellaneous Commercial Services | Director/Board Member | |
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services The University of Melbourne, founded in 1853, is a world-renowned institution located in Parkville, Australia. The university is a leader in education, teaching, and research, offering a wide range of coursework and research programs. | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| RESONANCE HEALTH LIMITED | Medical/Nursing Services | Chief Executive Officer | |
| University of Aberdeen | College/University | Undergraduate Degree | |
| ACRUX LIMITED | Pharmaceuticals: Major | Founder | |
| Rensselaer Polytechnic Institute | College/University | Masters Business Admin | |
| University of Connecticut | College/University | Undergraduate Degree | |
Commonwealth Scientific & Industrial Research Organisation
 Commonwealth Scientific & Industrial Research Organisation Miscellaneous Commercial ServicesCommercial Services Commonwealth Scientific & Industrial Research Organisation provides scientific and industrial research services. It plays a role in collaboration within the Australian national innovation system and as an advisor to government, industry and the community. The company was founded in 1916 and is headquartered in Canberra, Australia. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| The University of Western Australia | College/University | Corporate Officer/Principal | |
Brandon Capital Partners Pty Ltd.
 Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners Pty Ltd. (Brandon Capital Partners) is a venture capital firm founded in 2007 by David Fisher and Chris Nave. The firm is headquartered in Sydney, Australia. | Investment Managers | Chief Executive Officer | |
| DIMERIX LIMITED | Pharmaceuticals: Major | Chairman Director/Board Member | |
| OSPY MEDI CDI | Medical Specialties | Director/Board Member | |
Hatchtech Pty Ltd.
 Hatchtech Pty Ltd. Pharmaceuticals: MajorHealth Technology Hatchtech Pty Ltd. operates as pharmaceutical product company. It offers Xeglyze lotion that is head lice treatment. The company was founded by Vernon Morrison Bowles in 2001 and is headquartered in in Melbourne, Australia. | Pharmaceuticals: Major | Director/Board Member | |
| Glaucoma Foundation | Director/Board Member | ||
| BioMelbourne Network | Corporate Officer/Principal | ||
AusBiotech Ltd.
 AusBiotech Ltd. Miscellaneous Commercial ServicesCommercial Services AusBiotech Ltd. operates as an Australian biotechnology membership company. The private company is based in Melbourne, Australia. and has subsidiaries in Australia. The company was founded by Liz Dallimore. Lorraine Chiroiu has been the CEO of the company since 2008. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Glaxosmithkline Investments Pty Ltd.
 Glaxosmithkline Investments Pty Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline Investments Pty Ltd. is an Australian company. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Perron Institute for Neurological & Translational Science Ltd. | Director/Board Member | ||
Fibrotech Therapeutics Pty Ltd.
 Fibrotech Therapeutics Pty Ltd. Pharmaceuticals: MajorHealth Technology Fibrotech Therapeutics Pty Ltd develops novel drug candidates for the treatment of the fibrosis prevalent in such chronic conditions as kidney disease, chronic heart failure, pulmonary fibrosis, and arthritis. The company was founded by Richard Ernest Gilbert, Darren James Kelly, Spencer J Williams, Steven C Zammit, David Stapleton, Henry Krum and Yuan Zhang in 2006 and is headquartered in Melbourne, Australia. | Pharmaceuticals: Major | Chairman | |
| BAUSCH HEALTH COMPANIES INC. | Pharmaceuticals: Other | Sales & Marketing | |
Yuuwa Capital Management Pty Ltd.
 Yuuwa Capital Management Pty Ltd. Investment ManagersFinance Yuuwa Capital Management Pty Ltd. ( Yuuwa Capital Management ) is a venture capital firm, founded in 2009 by Liddy McCall , James Williams, Matthew Macfarlane. The firm is headquartered in Bentley, Western Australia. | Investment Managers | Founder | |
| Therapeutic Goods Administration | Corporate Officer/Principal | ||
| F.H. Faulding Pty Ltd. | Corporate Officer/Principal | ||
Fitgenes Australia Pty Ltd.
 Fitgenes Australia Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Fitgenes Ltd., Fitgenes Australia Pty Ltd. provides education on Nutrigenomics. The company is based in Brisbane, Australia. Fitgenes Australia was acquired by Fitgenes Ltd. | Miscellaneous Commercial Services | Director/Board Member | |
Otifex Therapeutics Pty Ltd.
 Otifex Therapeutics Pty Ltd. Medical SpecialtiesHealth Technology Otifex Therapeutics Pty Ltd. develops treatment for ear diseases. The company was founded by Burkhard Franz and Colin Anderson in 2009 and is headquartered in Melbourne, Australia. | Medical Specialties | Director/Board Member | |
Sprout Pharmaceuticals, Inc.
 Sprout Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sprout Pharmaceuticals, Inc. provides delivery of a treatment option for the unmet need of women with Hypoactive Sexual Desire Disorder. The company was founded by Cynthia E. Whitehead and Robert S. Whitehead on November 29, 2011 and is headquartered in Raleigh, NC. | Pharmaceuticals: Major | President | |
Global Kinetics Pty Ltd.
 Global Kinetics Pty Ltd. Medical SpecialtiesHealth Technology Global Kinetics Pty Ltd. provides point of care measurement and reporting of Parkinson's disease motor symptoms. Its product includes Personal KinetiGraph (PKG), a wrist worn medical device which reminds the patient when they have taken Levodopa medication as prescribed by doctor. The company was founded by Robert Griffiths and Malcolm Horne in 2007 and is headquartered in Melbourne, Australia. | Medical Specialties | Director/Board Member | |
| BACE Therapeutics Pty Ltd. | Director/Board Member | ||
| Argus Biomedical Pty Ltd. | Chief Executive Officer | ||
Nexgen Plants Pty Ltd.
 Nexgen Plants Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Nexgen Plants Pty Ltd. develops anti-viral technology solutions that enables virus resistant plant varieties to be developed for major food, fibre, energy and ornamental crops. The company was founded in 2013 and is headquartered in St. Lucia, Australia. | Miscellaneous Commercial Services | Director/Board Member | |
Dimerix Bioscience Pty Ltd.
 Dimerix Bioscience Pty Ltd. Medical DistributorsDistribution Services Dimerix Bioscience Pty Ltd. engages in the development and commercialization of drug therapies and drug discovery tools. It deals with clinical research organizations to progress its programs through clinical studies. It focuses on the clinical development of its therapeutic product DMX200 which is targeted to treat patients with chronic kidney disease. The company was founded by James Howard Williams on December 16, 2004 and is headquartered in Melbourne, Australia. | Medical Distributors | Chief Executive Officer | |
| Eridan Technology Pty Ltd. | Director/Board Member | ||
OccuRx Pty Ltd
 OccuRx Pty Ltd BiotechnologyHealth Technology OccuRx Pty Ltd provides biopharmaceutical services. It engages in the development of therapeutic strategies for the treatment of ophthalmic disorders associated with retinal fibrosis and inflammation. The company was founded by Darren J. Kelly in 2014 and is headquartered in Melbourne, Australia. | Biotechnology | Chairman | |
| ICETANA LIMITED | Packaged Software | Director/Board Member Director/Board Member | |
Yuuwa Capital LP
 Yuuwa Capital LP Investment ManagersFinance Yuuwa Capital LP seeks investment opportunities in the companies located in Australia primarily in Perth. The fund focuses on companies operating in the fields of software, information & communications technology ventures, life sciences and biotech sectors. It provides financing for early & seed stage capital requirements with investment size ranges between $1 million to $5 million. | Investment Managers | Founder | |
Azura Ophthalmics Pty Ltd.
 Azura Ophthalmics Pty Ltd. Medical SpecialtiesHealth Technology Azura Ophthalmics Ltd. develops therapies for meibomian gland dysfunction. It offers a portfolio of compounds in combination with a novel drug delivery platform to advance a portfolio of treatments for meibomian gland dysfunction. The company was founded by Yair Alster in 1980 and is headquartered in Tel Aviv, Israel. | Medical Specialties | Director/Board Member | |
Cardiora Pty Ltd.
 Cardiora Pty Ltd. Investment Trusts/Mutual FundsMiscellaneous Cardiora Pty Ltd. functions as a clinical stage pharmaceutical company. It develops CRD-102, an oral medicine for heart failure. The company was founded by David Kaye in 2015 and is headquartered in Melbourne, Australia. | Investment Trusts/Mutual Funds | Director/Board Member | |
Baker Heart & Diabetes Institute
 Baker Heart & Diabetes Institute Miscellaneous Commercial ServicesCommercial Services Baker Heart & Diabetes Institute owns and operates a medical research institute. The company is headquartered in Melbourne, Australia. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Athena Medicines Pty Ltd. | Director/Board Member | ||
Visus Therapeutics, Inc.
 Visus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Visus Therapeutics, Inc. is a clinical stage biopharmaceutical company that focuses on developing multi-targeted ophthalmic therapeutics for the front and back of the eye. The company is based in Seattle, WA and has subsidiaries in the United States. The company is developing novel, pupil-modulating therapeutics designed to correct the loss of near vision associated with presbyopia. In parallel, Visus is advancing its pipeline of early-stage ophthalmic drug candidates engineered to preserve and restore visual function associated with the leading causes of vision loss including cataract and presbyopia, ocular surface and corneal disease, glaucoma, and age-related macular degeneration. The company was founded by Benjamin Scot Bergo, Rhett M. Schiffman, and Benjamin Scot Bergo has been the CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member | |
| Supertrans Medical Ltd. | Director/Board Member | ||
| TMV Associates LLC | Corporate Officer/Principal | ||
| Ophthalmic World Leaders | Corporate Officer/Principal | ||
| Aleia Therapeutics Pty Ltd. | Director/Board Member | ||
| Demagtech Pty Ltd. | Director/Board Member |
Statistics
International
| Australia | 35 |
| United States | 13 |
| United Kingdom | 2 |
| Switzerland | 2 |
| Israel | 2 |
Sectoral
| Health Technology | 18 |
| Commercial Services | 7 |
| Consumer Services | 6 |
| Finance | 5 |
| Health Services | 2 |
Operational
| Director/Board Member | 41 |
| Corporate Officer/Principal | 13 |
| Founder | 6 |
| Chief Executive Officer | 6 |
| Chairman | 5 |
Most connected contacts
| Insiders | |
|---|---|
| Chris Nave | 24 |
| Williams James | 22 |
| Tracy M. Valorie | 13 |
| Russell John Tait | 5 |
| Clinton Snow | 4 |
| Barrie Charles Finnin | 3 |
- Stock Market
- Insiders
- Andrew Donohue
- Company connections